Fatigue Management Programs for People With MS
Comparing the Effectiveness of Fatigue Management Programs for People With MS
What it found
Results are posted in the registry, but without a statistical test of the main measure. See the numbers below.
What was tested
Treatment tested
- Teleconference
- Internet
- 1-to-1, in-person or videoconference
Results by group
Change From Baseline in Fatigue Levels
Change from baseline to 6 months
| Group | Value | Interval | Number analysed |
|---|---|---|---|
| Teleconference | 50.98 score on a scale | 2.08 (Standard Deviation) | 196 |
| Internet | 56.88 score on a scale | 0.59 (Standard Deviation) | 197 |
| One-to-one | 57.87 score on a scale | 1.34 (Standard Deviation) | 197 |
Teleconference
Internet
One-to-one
Values as posted on ClinicalTrials.gov. Outcomes measured differently across trials are not directly comparable.
Safety
| Group | Participants at risk | Serious adverse events | Deaths |
|---|---|---|---|
| Teleconference | 196 | 0 (0.0%) | 0 |
| Internet | 197 | 0 (0.0%) | 0 |
| One-to-One | 197 | 0 (0.0%) | 0 |
As posted on ClinicalTrials.gov. Serious adverse events include any serious health event during the trial, whether or not the treatment caused it.
What it measured
Main measures
Change From Baseline in Fatigue Levels
Change from baseline to 6 months
Fatigue
Other measures (1)
Change From Baseline in Health-related Quality of Life: Psychological Composite
Change from baseline to 6 months
Quality of life (reported by participants)
Who could take part
MS (type not specified) · 18 and over
Show the full criteria
Inclusion criteria
* Self-report diagnosis of MS * Age ≥ 18 years * Fatigue Severity Scale score ≥ 4 * Ability to speak English
Exclusion criteria
* Individual must be capable of providing consent (Assessed with questionnaire) * Unable to access the internet or unable to travel to in-person sessions
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
This is a multi-site randomized clinical trial comparing 3 modes of delivering the Managing Fatigue course for reducing fatigue in individuals with multiple sclerosis (MS). The primary hypothesis is that the teleconference and internet versions of the course will be noninferior to the one-on-one, in person version in terms of the primary outcome of fatigue and secondary outcome of quality of life.
Papers
Loading reviews and guidelines…
Linked trials
Referred to by
Offering Support and Electronic Resources for Care Partners of Those WNot a drug-phase study · Completed
Links found where a registry record names another trial's registry number.
History
Started
Mar 2019
Main results due
Apr 2023
Finished
Apr 2023
Results posted
Sept 2024